Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

20%

1 of 5 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT05540457Not ApplicableCompleted

Evaluation of Non-Invasive Continuous vs Intermittent BloodPressure Monitors in Maintenance Dialysis (BP Dialysis)

Role: collaborator

NCT05947708Not ApplicableCompleted

The Study of Intradialytic Symptoms in Subjects Treated With Qd 500vs Qd 300

Role: lead

NCT04526301Unknown

Home With TablO outcoMEs (HOME) Registry

Role: lead

NCT04912024Completed

Comparative Outcome Measures of Patients Receiving Acute Renal ThErapy Study

Role: lead

NCT04912050Completed

EXtension of Tablo TrEatmeNt Duration Registry

Role: lead

NCT02460263Not ApplicableCompleted

The EvAluation of TaBlo In-CLinic and In-HOme

Role: lead

All 6 trials loaded